CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($) $ in Millions	Total	Total Dentsply Sirona Equity	Common Stock	Capital in Excess of Par Value	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Treasury Stock	Noncontrolling Interests
Beginning Balance at Dec. 31, 2020	$ 4,935	$ 4,932	$ 3	$ 6,604	$ 1,198	$ (464)	$ (2,409)	$ 3
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	411	411			411
Other comprehensive loss	(130)	(128)				(128)		(2)
Exercise of stock options	52	52		15			37
Stock based compensation expense	49	49		49
Funding of employee stock purchase plan	5	5		2			3
Treasury shares purchased	(200)	(200)					(200)
Restricted stock unit distributions	(31)	(31)		(65)			34
Restricted stock unit dividends	0	0		1	(1)
Cash dividends declared	(94)	(94)			(94)
Ending Balance at Dec. 31, 2021	4,997	4,996	3	6,606	1,514	(592)	(2,535)	1
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(950)	(950)			(950)
Other comprehensive loss	(36)	(36)				(36)
Exercise of stock options	7	7		1			6
Stock based compensation expense	59	59		59
Funding of employee stock purchase plan	6	6		1			5
Treasury shares purchased	(150)	(150)					(150)
Restricted stock unit distributions	(13)	(13)		(38)			25
Cash dividends declared	(108)	(108)			(108)
Ending Balance at Dec. 31, 2022	3,812	3,811	3	6,629	456	(628)	(2,649)	1
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(132)	(132)			(132)
Other comprehensive loss	(8)	(8)				(8)
Exercise of stock options	0	0		(1)			1
Stock based compensation expense	46	46		46
Funding of employee stock purchase plan	6	6					6
Treasury shares purchased	(303)	(303)					(303)
Restricted stock unit distributions	(9)	(9)		(32)			23
Restricted stock unit dividends	0	0		1	(1)
Cash dividends declared	(118)	(118)			(118)
Ending Balance at Dec. 31, 2023	$ 3,294	$ 3,293	$ 3	$ 6,643	$ 205	$ (636)	$ (2,922)	$ 1